 |
|
| -R-
|
| Radioprotection |
| Wang ZW, Zhou JM, Huang ZS, Yang AP, Liu ZC, Xia YF, Zeng YX, Zhu XF. Aloe polysaccharides mediated radioprotective effect through the inhibition of apoptosis. J Radiat Res 2004;45:447-454.
|
| Red Clover |
| Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Alt Med Rev 1999;4(5):304-329.
|
| Red Wine |
| Aggarwal BB, Bhardwa A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2841.
|
| Aziz MA, Kumar R, Ahmad. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 2003;23:17-28.
|
| Bernatova I, Pechanova O, Babal P, Kysela S, Stvrtina S, Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 2002;282:H942-H948.
|
| Briviba K, Pan L, Rechkemmer G. Red wine polyphenols inhibit the growth of colon carcinoma cells and modulate the activation pattern of mitogen-activated protein kinases. J Nutr 2002;132:2814-2818.
|
| Cronin JR. Comparing antioxidant values with the ORAC method. Alt Comp Therap 2004;10(3):167-170.
|
| Dixon RA, Xie DY, Sharma SB. Proanthocyanidins - a final frontier in flavonoid research? New Phytol 2005;165:9-28.
|
| Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Alt Med Rev 2000;5(2):144-151.
|
| Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, Gautam SC. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 2002;132:2076-2081.
|
| Ignatowicz E, Baer-Dubowska W. Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol J Pharmacol 2001;53:557-569.
|
| Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Can Therap 2004;3(1):71-84.
|
| Jiangang Z, Yuanzhu H, Qi C, Enhui W, Kejiang C, Wu J. Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J 2000;113(2):99-102.
|
| Konowalchuk J, Speirs JI. Virus inactivation by grapes and wines. Appl Environ Microbiol 1976;32(6):757-763.
|
| Lewis GRJ. Should doctors discourage nutritional supplementation? A cardiovascular approach. Heart Lung Circ 2004;13:245-251.
|
| Lin JK, Tsai SH. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc 1999;23(3):99-106.
|
| Monograph. Oligomeric Proanthocyanidins (OPCs). Alt Med Rev 2003;8(4):442-450.
|
| Nakamura Y, Tonogai Y. Effects of grape seed polyphenols on serum and hepatic lipid contents and fecal steroid excretion in normal and hypercholesterolemic rats. J Health Sci 2002;48(6):570-578.
|
| Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998;68:258-65.
|
| |
| Nuttall SL, Kendall MJ, Martin U. Antioxidant therapy for the prevention of cardiovascular disease. Q J Med 1999;92:239-244.
|
| Oak MH, El Bedoui J, Schini-Kerth BV. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 2005;16:1-8.
|
| Rapport L, Lockwood B. Proanthocyanidins and grape seed extract. Pharm J 2001;266:581-584.
|
| Rifici VA, Stephan EM, Schneider SH, Khachadurian AK. Red wine inhibits the cell-mediated oxidation of LDL and HDL. J Amer Coll Nutr 1999;18(2):137-143.
|
| Romero I, Paez A, Lujan FM, Berenguer A. Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells. Brit J Urol 2002;89:950-954.
|
| Saito M, Satoh S, Kojima N, Tada H, Sato M, Suzuki T, Senoo H, Habuchi T. Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 experession in rat kidneys with ischemia/reperfusion injury. Arch Histol Cytol 2005;68(1):41-49.
|
| Sanchez-Moreno C, Cao G, Ou B, Prior RL. Anthocyanin and proanthocyanidin content in selected white and red wines. Oxygen radical absorbance capacity comparison with nontraditional wines obtained from highbush blueberry. J Agric Food Chem 2003;51:4889-4896.
|
| |
| |
| Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr 1998; 128:1003-1007.
|
| Shaheen SO, Sterne JAC, Thompson RL, Songhurst CE, Margetts BM, Burney PGJ. Dietary antioxidants and asthma in adults. Am J Respir Crit Care Med 2001;164:1823-1828.
|
| Singh SUN, Casper RF, Fritz PC, Sukhu B, Ganss B, Girard B, Savouret JF, Tenebaum HC. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol 2000;167:183-195.
|
| Szende B, Tyihak E, Kiraly-Veghely Z. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp Mol Med 2000;32(2):88-92.
|
| Wolter F, Stein J. Resveratrol enhances the differentiation induced by butyrate in Caco-2 colon cancer cells. J Nutr 2002;132:2082-2086.
|
| Wollin S, Jones PJ. Alcohol, red wine and cardiovascular disease. J Nutr 2001;131:1401-1404.
|
| Yang YB, Piao YJ. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol Sin 2003;24(7):703-710.
|
| Refsum Disease |
| Martinez M, Vazquez E, Garcia-Silva MT, Manzanares J, Bertran JM, Castello F, Mougan I. Therapeutic effects of docosahexanoic acid ethyl ester in patients with generalized peroxisomal disorders. Am J Clin Nutr 2000;71:(suppl):376S-385S.
|
| Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tspipursky, Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (lutein antioxidant supplementation trial). Optom 2004;75(4):216-230.
|
| Renal Carcinoma |
| Borek C. Dietary antioxidants and human cancer. Integ Cancer Therap 2004;3(4):333-341.
|
| McCabe AJ, Wallace JMW, Gilmore WS, McGlynn H, Strain SJ. Docosahexeanoic acid reduces in vitro invasion of renal carcinoma by elevated levels of tissue inhibitor of metalloproteinase-1. J Nutr Biochem 2005;16:17-22.
|
| Renal Failure |
| de Gomez Dumm NT, Giammona AM, Touceda LA. Variations in the lipid profile of patients with chronic reneal failure treated with pyridoxine. Lipid Health Disease 2003;2(7):1-6.
|
| Renal Transplantation |
| Bsoul SA, Terezhalmy GT. Vitamin C in health and disease. J Contemp Dent Pract 2004;5(1):1-13.
|
| Saito M, Satoh S, Kojima N, Tada H, Sato M, Suzuki T, Senoo H, Habuchi T. Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 experession in rat kidneys with ischemia/reperfusion injury. Arch Histol Cytol 2005;68(1):41-49.
|
| Reproduction |
| Chen SS, Chang LS, Chen HW, Wei YH. Polymorphisms of glutathione S-transferase M1 and male infertility in Taiwanese patients with varicocele. Hum Reprod 2002;17(3):718-725.
|
| Restless Legs Syndrome |
| Juhl JH. Fibromyalgia and the serotonin pathway. Altern Med Rev 1998;3(5):367-375.
|
| Resveratrol |
| Aggarwal BB, Bhardwa A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2841.
|
| Aziz MA, Kumar R, Ahmad. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 2003;23:17-28.
|
| Bhat KPL, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 2001;61:7456-7463.
|
| Borek C. Dietary antioxidants and human cancer. Integ Cancer Therap 2004;3(4):333-341.
|
| Ignatowicz E, Baer-Dubowska W. Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol J Pharmacol 2001;53:557-569.
|
| Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.
|
| Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Can Therap 2004;3(1):71-84.
|
| Jiangang Z, Yuanzhu H, Qi C, Enhui W, Kejiang C, Wu J. Effects of resveratrol on oxidative modification of human low density lipoprotein. Chin Med J 2000;113(2):99-102.
|
| Kaput J, Rodriquez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004;16:166-177.
|
| Kim H, Hall P, Smith M, Kirk M, Prasain JK, Barnes S, Grubbs C. Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent. J Nutr 2004;134:3445S-3452S.
|
| Lin JK, Tsai SH. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc 1999;23(3):99-106.
|
| Oak MH, El Bedoui J, Schini-Kerth BV. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 2005;16:1-8.
|
| Saito M, Satoh S, Kojima N, Tada H, Sato M, Suzuki T, Senoo H, Habuchi T. Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 experession in rat kidneys with ischemia/reperfusion injury. Arch Histol Cytol 2005;68(1):41-49.
|
| Singh SUN, Casper RF, Fritz PC, Sukhu B, Ganss B, Girard B, Savouret JF, Tenebaum HC. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol 2000;167:183-195.
|
| Szende B, Tyihak E, Kiraly-Veghely Z. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp Mol Med 2000;32(2):88-92.
|
| Wolter F, Stein J. Resveratrol enhances the differentiation induced by butyrate in Caco-2 colon cancer cells. J Nutr 2002;132:2082-2086.
|
| Yang YB, Piao YJ. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol Sin 2003;24(7):703-710.
|
| Retina |
| Anderson RE, Maude MB, McClellan M, Matthes MT, Yasumura D, LaVail MA. Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol Vis 2002;8:351-358.
|
| SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retinal Eye Res 2005;24:87-138.
|
| Retinitis Pigmentosa |
| Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Opthamol Vis Sci 2001;42:1873-1881.
|
| Mongraph. Vaccinium myrtillus (bilberry). Alt Med Rev 2001;6(1):500-504.
|
| Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tspipursky, Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (lutein antioxidant supplementation trial). Optom 2004;75(4):216-230.
|
| Retinoblastoma |
| Aggarwal BB, Bhardwa A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2841.
|
| Retinoic Acid |
| Borek C. Dietary antioxidants and human cancer. Integ Cancer Therap 2004;3(4):333-341.
|
| Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 2004;3:19 doi: 10.1186/1475-2891-3-19.
|
| Fawzi WW, Msamanga G, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004;351:23-32.
|
| Harding KL, Judah RD, Grant CE. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Alt Med Rev 2003;8(3):319-330.
|
| Kaput J, Rodriquez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004;16:166-177.
|
| Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Alt Med Rev 1999;4(5):304-329.
|
| MacKay D, Miller AL. Nutritional support for wound healing. Altern Med Rev 2003;8(4):359-377.
|
| Milliman WB, Lamson DW, Brignall MS. Hepatitis C: a retrospective study, literature review, and naturopathic protocol. Alt Med Rev 2000;5(4):355-370.
|
| Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integrat Cancer Therap 2004;3(4):310-322.
|
| Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA. Cancer prevention by natural compounds. Drug Metab Pharmacokin 2004;19(4):245-263.
|
| Zhang XK. Vitamin A and apoptosis in prostate cancer. Endocrine-Related Cancer 2002;9:87-102.
|
| Retinopathy |
| Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Alt Med Rev 2000;5(2):144-151.
|
| Head KA. Isoflavones and other soy constituents in human health and disease. Altern Med Rev 1997;2(6):433-450.
|
| Klapcinska B, Derejczyk J, Wieczorowska-Tobis K, Sobczak A, Sadowska-Krepa E, Danch A. Antioxidant defense in centenarians (a preliminary study). Acta Bio Pol 2000;47(2):281-292.
|
| Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50:1938-1942.
|
| Monograph. Oligomeric Proanthocyanidins (OPCs). Alt Med Rev 2003;8(4):442-450.
|
| Mongraph. Vaccinium myrtillus (bilberry). Alt Med Rev 2001;6(1):500-504.
|
| O'Donovan DJ, Fernandes CJ. Free radicals and diseases in premature infants. Antioxid Redox Signal 2004;6(1):169-176.
|
| SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retinal Eye Res 2005;24:87-138.
|
| Rhabdomyolysis |
| Saito M, Satoh S, Kojima N, Tada H, Sato M, Suzuki T, Senoo H, Habuchi T. Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 experession in rat kidneys with ischemia/reperfusion injury. Arch Histol Cytol 2005;68(1):41-49.
|
| Rheumatism |
| Hostanska K, Nisslein T, Freudenstein F, Reichling J, Saller R. Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol Pharm Bull 2004;27(12):1970-1975.
|
| Rheumatoid Arthritis
|
| Ames PRJ, Alves J, Murat I, Isenberg DA, Nourooz-Zadez J. Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. Rheumatol 1999;38:529-534.
|
| Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med 2005;9:11-24.
|
| Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
|
| Ghosh D, Thejomoorthy P. Anti-inflammatory and analgesic activities of oleanolic acid 3-/3-glucoside (rdg-1) from Randia dumetorum (rubiaceaea). Ind J Pharmac 1983;15(4):331-342.
|
| Mongraph. Vaccinium myrtillus (bilberry). Alt Med Rev 2001;6(1):500-504.
|
| Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyan R. Pharmacokinetic study of 11-keto B-boswellic acid. Phytomed 2004;11:255-260.
|
| Watkins BA, Li Y, Lippman HE, Seifert MF. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med 2001;226(6):485-497.
|
| Ribavirin |
| Milliman WB, Lamson DW, Brignall MS. Hepatitis C: a retrospective study, literature review, and naturopathic protocol. Alt Med Rev 2000;5(4):355-370.
|
| Riboflavin
|
| Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity: relevance to genetic disease and polymorphisms. Am J Clin Nutr 2002;75:616-658.
|
| Fawzi WW, Msamanga G, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004;351:23-32.
|
| Folkers KF, Wolaniuk A, Vadhanavikit S. Enzymology of the response of the carpal tunnel syndrome to riboflavin and to combined riboflavin and pyridoxine. Proc Natl Acad Sci 1984;81:7076-7078.
|
| Harding KL, Judah RD, Grant CE. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Alt Med Rev 2003;8(3):319-330.
|
| Juhl JH. Fibromyalgia and the serotonin pathway. Altern Med Rev 1998;3(5):367-375.
|
| Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Alt Med Rev 2000;5(5):402-428.
|
| Klapcinska B, Derejczyk J, Wieczorowska-Tobis K, Sobczak A, Sadowska-Krepa E, Danch A. Antioxidant defense in centenarians (a preliminary study). Acta Bio Pol 2000;47(2):281-292.
|
| Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tspipursky, Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (lutein antioxidant supplementation trial). Optom 2004;75(4):216-230.
|
| Rice Bran |
| Arruzazabala ML, Menendez MNR, Carbajal RMD, Valdes S, Molina V. Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia. Braz J Med Biol Res 2000;33(7):835-840.
|
| Rickets |
| Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A. Serum levels of 25-hydroxyvitamin D and functional recovery after hip fracture. Arch Phys Med Reabil 2005;86:64-68.
|
| Ritalin |
| Harding KL, Judah RD, Grant CE. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Alt Med Rev 2003;8(3):319-330.
|
| Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Alt Med Rev 2000;5(5):402-428.
|
| Rofecoxib |
| Horton R. Vioxx, the implosion of Merck, and aftershocks at the FDA. Lancet 2004;364(9446):1-2.
|
| Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofexcoxib: cumulative meta-analysis. Lancet 2004;364(9446)1-9.
|
|
|
| |
